Kiniksa Pharmaceuticals LtdEigentümerstruktur
| Preis (2026-07-29) | 52W Hoch | 52W Tief |
| 80.92 USD | 82,94 USD | 29,9 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 78,75 USD | 4 | 2 | 0 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 48.289.273 | 11,87 | 4,34 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Kiniksa Pharmaceuticals Ltd
Mitarbeiter 366
Handelsplatz NASDAQ
Ticker Symbol KNSA
IPO Datum 2018-05-24
Adresse 105 Piccadilly, London, United Kingdom, W1J 7NJ
Webseite https://www.kiniksa.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Sanjiv K. Patel | CEO & Chairman of the Board |
| 2 | Mr. Mark A. Ragosa C.F.A. | Executive VP & CFO |
| 3 | Mr. Ross Michael Moat | Executive VP, COO & Principal Operating Officer |
| 4 | Dr. John F. Paolini FACC, M.D., Ph.D. | Executive VP & Chief Medical Officer |
| 5 | Mr. Eben Tessari | Consultant |
| 6 | Mr. Michael R. Megna CPA | Senior VP & Chief Accounting Officer |
| 7 | Ms. Mei Jang | Senior VP & Chief Technical Officer |
| 8 | Mr. Jonathan Kirshenbaum | Investor Relations Officer |
| 9 | Mr. Douglas J. Barry | Senior VP, Chief Legal Officer & Secretary |
| 10 | Ms. Martina Struck Ph.D. | Senior VP & Chief Regulatory Officer |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | FMR Inc | 0,00% | 0,00 Mio. USD |
| 2 | Rubric Capital Management LP | 0,00% | 0,00 Mio. USD |
| 3 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 4 | Baker Bros Advisors LP | 0,00% | 0,00 Mio. USD |
| 5 | TANG CAPITAL MANAGEMENT LLC | 0,00% | 0,00 Mio. USD |
| 6 | Vanguard Portfolio Management, LLC | 0,00% | 0,00 Mio. USD |
| 7 | Acadian Asset Management LLC | 0,00% | 0,00 Mio. USD |
| 8 | Vanguard Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 9 | Morgan Stanley - Brokerage Accounts | 0,00% | 0,00 Mio. USD |
| 10 | D. E. Shaw & Co LP | 0,00% | 0,00 Mio. USD |
| 11 | Arrowstreet Capital Limited Partnership | 0,00% | 0,00 Mio. USD |
| 12 | Dimensional Fund Advisors, Inc. | 0,00% | 0,00 Mio. USD |
| 13 | Spruce Street Capital LP | 0,00% | 0,00 Mio. USD |
| 14 | Bank of America Corp | 0,00% | 0,00 Mio. USD |
| 15 | Qube Research & Technologies | 0,00% | 0,00 Mio. USD |
| 16 | Connor Clark & Lunn Inv Mgmt Ltd | 0,00% | 0,00 Mio. USD |
| 17 | BNP Paribas Arbitrage, SA | 0,00% | 0,00 Mio. USD |
| 18 | Point72 Asset Management, L.P. | 0,00% | 0,00 Mio. USD |
| 19 | SG Americas Securities, LLC | 0,00% | 0,00 Mio. USD |
| 20 | Pictet Asset Manangement SA | 0,00% | 0,00 Mio. USD |